5AM Ventures is a financial company that’s making a huge impact in the science world. The financial firm’s main goal is to help fund new techniques in the science, medical, and technological fields. One of the people who is pushing 5AM Ventures to the forefront of the business world is it’s managing partner Scott Rocklage.
Rocklage’s experience dates in the medical field dates back over thirty years. After graduating from the University of California, Berkley with a degree in Chemistry, Rocklage wanted to further his studies. He enrolled at Massachusetts Institute of Technology, where he earned a Ph.D. in Chemistry. Following school, Rocklage went to work for biotechnology and medical companies such as Relypsa, Cubist Pharmaceuticals, and EntreMed. Rocklage’s positions with these companies included: Executive Chairman, President, and CEO.
Throughout Scott Rocklage’s career, he helped get FDA approvals for the following drugs; Omniscan, Teslascan, and Cubicin. Aside from the FDA approvals, he also helped candidates enter clinical trials for new drugs.
With his knowledge of the medical world, it’s no wonder that Scott Rocklage wants to continue making strides. In 2003, Scott Rocklage made the biggest move of his career when he became a partner in the new company 5AM Ventures. Thanks to his company 5AM Ventures, he’s helping scientists and entrepreneurs create new medicines and technology to shape the healthcare industry. The company has invested in many organizations such as Pulmatrix, Rennovia, Achaogen, and Semprus Biosciences. Learn more:
With healthcare being a major issue in society, Scott Rocklage and his company 5AM Ventures are continuing their goal of finding new advancements in the medical world.
Learn more here: